High FOSL1 expression is associated with poor overall survival in lung adenocarcinoma, pancreatic adenocarcinoma, clear cell renal cell carcinoma, sarcoma, low grade glioma, glioblastoma, head and neck squamous carcinoma (HNSCC), and uveal melanoma (Fig. 7A). Here, FOSL1 is linked to central nervous system cancer.